Tags: ms + study.with.MS
-
Neutralizing antibody (NAbs) positivity does not reduce the efficacy of interferon beta-1b (IFNbeta-1b) treatment, according to results of a substudy analysis of patients with a first event suggestive of multiple sclerosis (MS) in a multicentre, randomize
-
Therefore, these findings demonstrate not only that pregnancy has no adverse effects on the rate of MS relapses, but it also provides further evidence of the beneficial effects both of pregnancy and the postpartum period, over the long term, indicating a
-
The BENEFIT study (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment), sponsored by Bayer HealthCare, compared Betaseron treatment initiated after a first clinical event with delayed treatment.
-
Argentinean researchers conducted a small study to try to determine if parasitic worm infections conferred any benefits on MS sufferers.
-
Acquiring a regular tan during childhood may help to protect against the development of multiple sclerosis (MS) in later life, US research of twin pairs reveals.
-
The cost of MS to the Canadian economy is estimated to be more than $1 billion per year.
-
Reporting in the May issue of the journal Archives of Neurology, Dr. Rhonda Voskuhl, the director of UCLA’s Multiple Sclerosis Program, and her colleagues have found that the application of a testosterone gel for men with MS reduced symptoms, slowed bra
-
Campath-1H is a potentially new treatment for Multiple Sclerosis or MS. It is currently undergoing trials in the UK, USA, Russia, Italy and Croatia to determine whether it can help those with an early form of MS.
First / Previous / Next / Last / Page 1 of 1